Biography
Dr. Franc is a Clinical Professor of Radiology - Nuclear Medicine and Molecular Imaging. He completed his B.S and M.S. in Chemical Engineering at Stanford University, Stanford, CA. He completed his medical school training at University of Southern California, Keck School of Medicine. While conducting his residency at Stanford University, in the Division of Nuclear Medicine and Molecular Imaging, he was also the chief resident. Dr. Franc’s research interests include all aspects of PET-CT as he has nearly 20 years of experience in clinical Nuclear Medicine with particular expertise in PET-CT.
Dr. Franc predominantly publishes and lectures on applications and innovations of PET-CT. He has proficiency in all aspects of PET radiopharmaceutical development, spanning the design of molecules, synthesis of radioligands, and use in animal and human imaging. He also has expertise in quantitative image analysis, development of novel post-processing image reconstruction methods, and the application of artificial intelligence in human diagnostics. Dr. Franc has implemented new radiopharmaceuticals in pre-clinical and clinical research PET imaging as well as for clinical PET with applications in cancer, infectious disease (HIV), and autoimmune disease (RA). He has applied advanced computational techniques, including deep learning, to extract predictive data for prognosis of various cancers and neurodegenerative diseases from molecular imaging modalities.
Since joining the faculty at Stanford in 2018, Dr. Franc has received several awards including the Radiological Society of North America 2019 Margulis Award for Excellence in Research; RSNA 2019 Trainee Research; and Most read article in Radiology 2019. He has accepted the position of Director, Residency Program, Nuclear Medicine and Molecular Imaging as well as the Director, Radiology Value-Based Care Initiative. Dr. Franc has presented more than 40 abstracts at national and international meetings and published more than 90 papers in peer-reviewed publications, as well as 9 book chapters.
Dr. Franc predominantly publishes and lectures on applications and innovations of PET-CT. He has proficiency in all aspects of PET radiopharmaceutical development, spanning the design of molecules, synthesis of radioligands, and use in animal and human imaging. He also has expertise in quantitative image analysis, development of novel post-processing image reconstruction methods, and the application of artificial intelligence in human diagnostics. Dr. Franc has implemented new radiopharmaceuticals in pre-clinical and clinical research PET imaging as well as for clinical PET with applications in cancer, infectious disease (HIV), and autoimmune disease (RA). He has applied advanced computational techniques, including deep learning, to extract predictive data for prognosis of various cancers and neurodegenerative diseases from molecular imaging modalities.
Since joining the faculty at Stanford in 2018, Dr. Franc has received several awards including the Radiological Society of North America 2019 Margulis Award for Excellence in Research; RSNA 2019 Trainee Research; and Most read article in Radiology 2019. He has accepted the position of Director, Residency Program, Nuclear Medicine and Molecular Imaging as well as the Director, Radiology Value-Based Care Initiative. Dr. Franc has presented more than 40 abstracts at national and international meetings and published more than 90 papers in peer-reviewed publications, as well as 9 book chapters.
View Full Biography
Professional Summary
Education & Certifications
- Board Certification: American Board of Nuclear Medicine, Nuclear Medicine (2022)
- Internship: Stanford University Dept of General Surgery (2001) CA
- Medical Education: University of Southern California Keck School of Medicine (2000) CA
-
- Residency: Stanford University Nuclear Medicine Residency (2003) CA
Publications
-
Low uptake of Tc-99m tetrofosmin in lung cancer - A case report
Franc, B., & Goris, M. (2002). Low uptake of Tc-99m tetrofosmin in lung cancer - A case report. CLINICAL NUCLEAR MEDICINE, 27(10), 698–700. -
Oral administration of F-18FDG to evaluate a single pulmonary nodule by positron emission tomography in a patient with poor intravenous access
Franc, B., Carlisle, M. R., & Segall, G. (2003). Oral administration of F-18FDG to evaluate a single pulmonary nodule by positron emission tomography in a patient with poor intravenous access. CLINICAL NUCLEAR MEDICINE, 28(7), 541–44. -
Apoptosis in a rodent model of cranial suture fusion: In situ imaging and gene expression analysis
Fong, K. D., Song, H. M., Nacamuli, R. P., Franc, B. L., Mari, C., Fang, T. D., … Longaker, M. T. (2004). Apoptosis in a rodent model of cranial suture fusion: In situ imaging and gene expression analysis. PLASTIC AND RECONSTRUCTIVE SURGERY, 113(7), 2037–47. -
-
Pericardial lymph node involvement in lymphoma as identified on PET
Franc, B., Yoshida, E., Herfkens, R., & Goris, M. (2004). Pericardial lymph node involvement in lymphoma as identified on PET. CLINICAL NUCLEAR MEDICINE, 29(11), 741–42. -
Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation
Goun, E. A., Shinde, R., Dehnert, K. W., Adams-Bond, A., Wender, P. A., Contag, C. H., & Franc, B. L. (2006). Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation. BIOCONJUGATE CHEMISTRY, 17(3), 787–96. -
Correcting tumour SUV for enhanced bone marrow uptake: retrospective F-18-FDG PET/CT studies
Teo, B.-K., Badiee, S., Hadi, M., Lam, T., Johnson, L., Seo, Y., … Franc, B. L. (2008). Correcting tumour SUV for enhanced bone marrow uptake: retrospective F-18-FDG PET/CT studies. NUCLEAR MEDICINE COMMUNICATIONS, 29(4), 359–66. -
Diagnostic value of PET/CT for the staging and restaging of pediatric tumors
Kleis, M., Daldrup-Link, H., Matthay, K., Goldsby, R., Lu, Y., Schuster, T., … Franc, B. L. (2009). Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 36(1), 23–36. -
Breaching biological barriers: protein translocation domains as tools for molecular imaging and therapy.
Franc, B. L., Mandl, S. J., Siprashvili, Z., Wender, P., & Contag, C. H. (2003). Breaching biological barriers: protein translocation domains as tools for molecular imaging and therapy. Molecular Imaging, 2(4), 313–23. -
Development of an optimized activatable MMP-14 targeted SPECT imaging probe
Watkins, G. A., Jones, E. F., Shell, M. S., VanBrocklin, H. F., Pan, M.-hsiu, Hanrahan, S. M., … Franc, B. L. (2009). Development of an optimized activatable MMP-14 targeted SPECT imaging probe. BIOORGANIC & MEDICINAL CHEMISTRY, 17(2), 653–59. -
The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma
Franc, B. L., Mari, C., Johnson, D., & Leong, S. P. (2005). The role of a positron- and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. CLINICAL NUCLEAR MEDICINE, 30(12), 787–91. -
A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant.
Ronald, J. A., Kim, B.-S., Gowrishankar, G., Namavari, M., Alam, I. S., D'Souza, A., … Gambhir, S. S. (2017). A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Research, 77(11), 2893–2902. -
Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT.
Kleis, M. A., Daldrup-Link, H., Goldsby, R., Hawkins, R. A., & Franc, B. L. (2009). Multiple Scalp Lesions in a Patient with Keratitis, Ichthyosis and Deafness Syndrome Mimicking Metastatic Squamous Cell Carcinoma on 18F-FDG PET/CT. Radiology Case Reports, 4(2), 218-? -
Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise
Shaikh, F., Franc, B., Allen, E., Sala, E., Awan, O., Hendrata, K., … Shrestha, R. (2018). Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 2: From Clinical Implementation to Enterprise. JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 15(3), 543–49. -
Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 1: From Methodology to Clinical Implementation
Shaikh, F., Franc, B., Allen, E., Sala, E., Awan, O., Hendrata, K., … Shrestha, R. (2018). Translational Radiomics: Defining the Strategy Pipeline and Considerations for Application-Part 1: From Methodology to Clinical Implementation. JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 15(3), 538–42. -
Prospective Evaluation of F-18-DCFPyL PET/CT and Conventional Imaging in Patients with Biochemically Recurrent Prostate Cancer
Song, H., Harrison, C., Guja, K., Franc, B., Moradi, F., Davidzon, G., … Iagaru, A. (2019). Prospective Evaluation of F-18-DCFPyL PET/CT and Conventional Imaging in Patients with Biochemically Recurrent Prostate Cancer. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prospective Comparison of F-18-DCFPyL PET/CT with F-18-NaF PET/CT for Detection of Skeletal Metastases in Biochemically Recurrent Prostate Cancer
Duan, H., Song, H., Baratto, L., Khalaf, M., Hatami, N., Franc, B., … Iagaru, A. (2019). Prospective Comparison of F-18-DCFPyL PET/CT with F-18-NaF PET/CT for Detection of Skeletal Metastases in Biochemically Recurrent Prostate Cancer. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prospective evaluation of F-18- DCFPyL in Patients with Biochemically Recurrent Prostate Cancer: Positivity Rate and Correlation with PSA levels
Harrison, C., Song, H., Franc, B. L., Guja, K., Moradi, F., Davidzon, G., … Iagaru, A. (2019). Prospective evaluation of F-18- DCFPyL in Patients with Biochemically Recurrent Prostate Cancer: Positivity Rate and Correlation with PSA levels. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prospective Evaluation in an Academic Center of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: A Focus on Localizing Disease and Changes in Management.
Song, H., Harrison, C., Duan, H., Guja, K., Hatami, N., Franc, B., … Iagaru, A. (2019). Prospective Evaluation in an Academic Center of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: A Focus on Localizing Disease and Changes in Management. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans.
Nobashi, T., Zacharias, C., Ellis, J. K., Ferri, V., Koran, M. E., Franc, B. L., … Davidzon, G. A. (2019). Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans. Journal of Digital Imaging. -
Identifying tests related to breast cancer care in claims data.
Franc, B. L., Thombley, R., Luo, Y., Boscardin, W. J., Rugo, H. S., Seidenwurm, D., & Dudley, R. A. (2019). Identifying tests related to breast cancer care in claims data. The Breast Journal. -
Fungal endocarditis resembling primary cardiac malignancy in a patient with B-cell ALL with culture confirmation.
Girod, B. J., Guja, K. E., Davidzon, G., Chan, F., Zucker, E., Franc, B. L., … Aparici, C. M. (2020). Fungal endocarditis resembling primary cardiac malignancy in a patient with B-cell ALL with culture confirmation. Radiology Case Reports, 15(2), 117–19. -
Potential role for antiangiogenic proteins in the myocardial infarction repair process
Thompson, J. L., Ryan, J. A., Barr, M. L., Franc, B., Starnes, V. A., & Schwarz, M. A. (2004). Potential role for antiangiogenic proteins in the myocardial infarction repair process. JOURNAL OF SURGICAL RESEARCH, 116(1), 156–64. -
Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system
Seo, Y., Wong, K. H., Sun, M. S., Franc, B. L., Hawkins, R. A., & Hasegawa, B. H. (2005). Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. JOURNAL OF NUCLEAR MEDICINE, 46(5), 868–77. -
Improved prostate cancer imaging with SPECT/CT and MRI/MRSI
Seo, Y., Kurhanewicz, J., Franc, B. L., Hawkins, R. A., & Hasegawa, B. H. (2005). Improved prostate cancer imaging with SPECT/CT and MRI/MRSI. IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 52(5), 1316–20. -
FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation
O'Conner, A. R., & Franc, B. L. (2005). FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. NUCLEAR MEDICINE COMMUNICATIONS, 26(12), 1107–11. -
Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy
Lin, D., Franc, B. L., Kashani-Sabet, M., & Singer, M. I. (2006). Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 28(3), 249–55. -
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to neuroblastoma therapy consortium study
Matthay, K. K., Tan, J. C., Villablanca, J. G., Yanik, G. A., Veatch, J., Franc, B., … Maris, J. M. (2006). Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to neuroblastoma therapy consortium study. JOURNAL OF CLINICAL ONCOLOGY, 24(3), 500–506. -
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
Messina, J. A., Cheng, S.-C., Franc, B. L., Charron, M., Shulkin, B., To, B., … Matthay, K. K. (2006). Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. PEDIATRIC BLOOD & CANCER, 47(7), 865–74. -
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma
Raz, D. J., Odisho, A. Y., Franc, B. L., & Jablons, D. M. (2006). Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 132(5), 1189–95. -
Progress in SPECT/CT imaging of prostate cancer
Seo, Y., Franc, B. L., Hawkins, R. A., Wong, K. H., & Hasegawa, B. H. (2006). Progress in SPECT/CT imaging of prostate cancer. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 5(4), 329–36. -
Rodent Brain Imaging with SPECT and CT
Seo, Y., Gao, D.-W., Hashimoto, T., Franc, B. L., Dae, M. W., & Hasegawa, B. H. (2006). Rodent Brain Imaging with SPECT and CT. 2006 IEEE NUCLEAR SCIENCE SYMPOSIUM CONFERENCE RECORD, VOL 1-6, 3526-+. -
Partial-volume correction in PET: Validation of an iterative postreconstruction method with phantom and patient data
Teo, B.-K., Seo, Y., Bacharach, S. L., Carrasquillo, J. A., Libutti, S. K., Shukla, H., … Franc, B. L. (2007). Partial-volume correction in PET: Validation of an iterative postreconstruction method with phantom and patient data. JOURNAL OF NUCLEAR MEDICINE, 48(5), 802–10. -
Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma
Falk, M. S., Truitt, A. K., Coakley, F. V., Kashani-Sabet, M., Hawkins, R. A., & Franc, B. (2007). Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. NUCLEAR MEDICINE COMMUNICATIONS, 28(4), 273–80. -
An automatic method to delineate 18F-FDG PET tumor volumes for radiation treatment planning
Teo, B.-K., Seo, Y., Xia, P., Bacharach, S. L., Franc, B. L., & Hasegawa, B. H. (2007). An automatic method to delineate 18F-FDG PET tumor volumes for radiation treatment planning. MEDICAL PHYSICS, 34(6), 2397–98. -
Rodent brain imaging with SPECT/CT
Seo, Y., Gao, D.-W., Hasegawa, B. H., Dae, M. W., & Franc, B. L. (2007). Rodent brain imaging with SPECT/CT. MEDICAL PHYSICS, 34(4), 1217–20. -
Calciphylaxis and bone scintigraphy: case report with histological confirmation and review of the literature
Han, M. M., Pang, J., Shinkai, K., Franc, B., Hawkins, R., & Aparici, C. M. (2007). Calciphylaxis and bone scintigraphy: case report with histological confirmation and review of the literature. ANNALS OF NUCLEAR MEDICINE, 21(4), 235–38. -
Case 110: Nonossifying fibroma.
Hetts, S. W., Hilchey, S. D., Wilson, R., & Franc, B. (2007). Case 110: Nonossifying fibroma. Radiology, 243(1), 288–92. -
Anterior layering of excreted F-18-FDG in the bladder on PET/CT: Frequency and cause
Purcell, D. D., Coakley, F. V., Franc, B. L., Hawkins, R. A., Boddington, S. E., & Yeh, B. M. (2007). Anterior layering of excreted F-18-FDG in the bladder on PET/CT: Frequency and cause. AMERICAN JOURNAL OF ROENTGENOLOGY, 189(2), W96–W99. -
Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient
Franc, B. L., & Hawkins, R. A. (2007). Positron emission tomography, positron emission tomography-computed tomography, and molecular imaging of the breast cancer patient. SEMINARS IN ROENTGENOLOGY, 42(4), 265–79. -
Telomeric transgenes are silenced in adult mouse tissues and embryo fibroblasts but are expressed in embryonic stem cells
Gao, Q., Reynolds, G. E., Innes, L., Pedram, M., Jones, E., Junabi, M., … Murnane, J. P. (2007). Telomeric transgenes are silenced in adult mouse tissues and embryo fibroblasts but are expressed in embryonic stem cells. STEM CELLS, 25(12), 3085–92. -
Assessment of the sources of error affecting the quantitative accuracy of SPECT imaging in small animals
Hwang, A. B., Franc, B. L., Gullberg, G. T., & Hasegawa, B. H. (2008). Assessment of the sources of error affecting the quantitative accuracy of SPECT imaging in small animals. PHYSICS IN MEDICINE AND BIOLOGY, 53(9), 2233–52. -
Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
Franc, B. L., Acton, P. D., Mari, C., & Hasegawa, B. H. (2008). Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation. JOURNAL OF NUCLEAR MEDICINE, 49(10), 1651–63. -
Nuclear medicine in the assessment of differentiated thyroid cancer
Rutherford, G.-C., Franc, B., & O'Connor, A. (2008). Nuclear medicine in the assessment of differentiated thyroid cancer. CLINICAL RADIOLOGY, 63(4), 453–63. -
In vivo imaging of mucosal CD4(+) T cells using single photon emission computed tomography in a murine model of colitis
Kanwar, B., Gao, D. W., Hwang, A. B., Grenert, J. P., Williams, S. P., Franc, B., & McCune, J. M. (2008). In vivo imaging of mucosal CD4(+) T cells using single photon emission computed tomography in a murine model of colitis. JOURNAL OF IMMUNOLOGICAL METHODS, 329(1-2), 21–30. -
Role of IV Iodinated Contrast Material in F-18-FDG PET/CT of Liver Metastases
Badiee, S., Franc, B. L., Webb, E. M., Chu, B., Hawkins, R. A., & Coakley, F. (2008). Role of IV Iodinated Contrast Material in F-18-FDG PET/CT of Liver Metastases. AMERICAN JOURNAL OF ROENTGENOLOGY, 191(5), 1436–39. -
Iodine-131-Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study
Matthay, K. K., Quach, A., Huberty, J., Franc, B. L., Hawkins, R. A., Jackson, H., … Maris, J. M. (2009). Iodine-131-Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study. JOURNAL OF CLINICAL ONCOLOGY, 27(7), 1020–25. -
Nanoprobes for medical diagnosis: Current status of nanotechnology in molecular imaging
He, J., VanBrocklin, H. F., Franc, B. L., Seo, Y., & Jones, E. F. (2008). Nanoprobes for medical diagnosis: Current status of nanotechnology in molecular imaging. CURRENT NANOSCIENCE, 4(1), 17–29. -
Biodistributions of Lu-177- and In-111-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of In-111-7E11 as a Pre-therapeutic Agent for Lu-177-7E11 Radioimmunotherapy
Pan, M.-H., Gao, D.-W., Feng, J., He, J., Seo, Y., Tedesco, J., … Franc, B. L. (2009). Biodistributions of Lu-177- and In-111-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of In-111-7E11 as a Pre-therapeutic Agent for Lu-177-7E11 Radioimmunotherapy. MOLECULAR IMAGING AND BIOLOGY, 11(3), 159–66. -
CAN POSITRON EMISSION TOMOGRAPHY (PET) OR PET/COMPUTED TOMOGRAPHY (CT) ACQUIRED IN A NONTREATMENT POSITION BE ACCURATELY REGISTERED TO A HEAD-AND-NECK RADIOTHERAPY PLANNING CT?
Hwang, A. B., Bacharach, S. L., Yom, S. S., Weinberg, V. K., Quivey, J. M., Franc, B. L., & Xia, P. (2009). CAN POSITRON EMISSION TOMOGRAPHY (PET) OR PET/COMPUTED TOMOGRAPHY (CT) ACQUIRED IN A NONTREATMENT POSITION BE ACCURATELY REGISTERED TO A HEAD-AND-NECK RADIOTHERAPY PLANNING CT? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 73(2), 578–84. -
Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma
Bidlingmaier, S., He, J., Wang, Y., An, F., Feng, J., Barbone, D., … Liu, B. (2009). Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma. CANCER RESEARCH, 69(4), 1570–77. -
Thyroid and Hepatic Function After High-Dose I-131-Metaiodobenzylguanidine (I-131-MIBG) Therapy for Neuroblastoma
Quach, A., Ji, L., Mishra, V., Sznewajs, A., Veatch, J., Huberty, J., … Matthay, K. K. (2011). Thyroid and Hepatic Function After High-Dose I-131-Metaiodobenzylguanidine (I-131-MIBG) Therapy for Neuroblastoma. PEDIATRIC BLOOD & CANCER, 56(2), 191–201. -
Patient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study.
Sayre, G. A., Franc, B. L., & Seo, Y. (2011). Patient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study. International Journal of Molecular Imaging, 2011, 185083. -
Improved techniques to localize foci of carcinoma within the prostate using high-resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA).
Franc, B. L., Cui, Y., Rosenthal, S. A., Johnston, T., Poonamallee, U., Wiesner, J. B., … James, R. (2012). Improved techniques to localize foci of carcinoma within the prostate using high-resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA). JOURNAL OF CLINICAL ONCOLOGY, 30(15). -
Clinical Utility of SPECT-(Low-Dose)CT Versus SPECT Alone in Patients Presenting for Bone Scintigraphy
Franc, B. L., Myers, R., Pounds, T. R., Bolton, G., Conte, F., Bartheld, M., & Da Silva, A. J. (2012). Clinical Utility of SPECT-(Low-Dose)CT Versus SPECT Alone in Patients Presenting for Bone Scintigraphy. CLINICAL NUCLEAR MEDICINE, 37(1), 26–34. -
Preclinical SPECT and SPECT/CT.
Seo, Y., Jiang, H., & Franc, B. L. (2013). Preclinical SPECT and SPECT/CT. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer, 187, 193–220. -
Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)-Proof of concept and initial imaging results
Franc, B. L., Cho, S. Y., Rosenthal, S. A., Cui, Y., Tsui, B., Vandewalker, K. M. N., … James, R. B. (2013). Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)-Proof of concept and initial imaging results. EUROPEAN JOURNAL OF RADIOLOGY, 82(11), 1877–84. -
Detection of Recurrent Non-Hodgkin Lymphoma on In-111 Capromab Pendetide Imaging
Franc, B. L., & Lin, H. (2015). Detection of Recurrent Non-Hodgkin Lymphoma on In-111 Capromab Pendetide Imaging. CLINICAL NUCLEAR MEDICINE, 40(7), 585–88. -
Overall and disease-free survival outcomes of patients receiving intensity-modulated radiation therapy (IMRT) with PET-CT-based planning for cancers of the head and neck
Franc, B. L., DeLemos, C., & Jones, C. (2015). Overall and disease-free survival outcomes of patients receiving intensity-modulated radiation therapy (IMRT) with PET-CT-based planning for cancers of the head and neck. JOURNAL OF RADIOTHERAPY IN PRACTICE, 14(3), 285–95. -
ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources
Spratt, D. E., Zaki, B. I., Franc, B. L., Hartford, A. C., & Osborne, J. R. (2016). ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources. CLINICAL NUCLEAR MEDICINE, 41(2), 106–17. -
Imaging Bone-Cartilage Interactions in Osteoarthritis Using [F-18]-NaF PET-MRI
Savic, D., Pedoia, V., Seo, Y., Yang, J., Bucknor, M., Franc, B. L., & Majumdar, S. (2016). Imaging Bone-Cartilage Interactions in Osteoarthritis Using [F-18]-NaF PET-MRI. MOLECULAR IMAGING, 15, 1–12. -
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
Jones, E. F., Ray, K. M., Li, W., Seo, Y., Franc, B. L., Chien, A. J., … Hylton, N. M. (2017). Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Breast Cancer, 17(3), e155–e159. -
Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000-2014
Copeland, T. P., Creasman, J. M., Seidenwurm, D. J., & Franc, B. L. (2017). Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000-2014. CURRENT ONCOLOGY, 24(2), E99–E105. -
Contextualizing Oncologic Imaging Utilization Through End-of-Life Spending Patterns
Copeland, T. P., Hillman, J. N., & Franc, B. L. (2017). Contextualizing Oncologic Imaging Utilization Through End-of-Life Spending Patterns. JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 14(10), 1269–78. -
In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis
Franc, B. L., Goth, S., MacKenzie, J., Li, X., Blecha, J., Lam, T., … VanBrocklin, H. (2017). In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. MOLECULAR IMAGING, 16, 1536012117712638. -
Delayed Fluorodeoxyglucose Positron Emission Tomography Imaging in the Differentiation of Tumor Recurrence and Radiation Necrosis in Pediatric Central Nervous System Tumors: Case Report and Review of the Literature.
Wadhwa, E. L., Franc, B. L., Aboian, M., Kim, J. Y., Pampaloni, M., & Nicolaides, T. (2018). Delayed Fluorodeoxyglucose Positron Emission Tomography Imaging in the Differentiation of Tumor Recurrence and Radiation Necrosis in Pediatric Central Nervous System Tumors: Case Report and Review of the Literature. Cureus, 10(9), e3364. -
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.
Huang, S.-Y. Y., Franc, B. L., Harnish, R. J., Liu, G., Mitra, D., Copeland, T. P., … Seo, Y. (2018). Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis. NPJ Breast Cancer, 4, 24. -
Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.
Franc, B. L., Copeland, T. P., Thombley, R., Park, M., Marafino, B., Dean, M. L., … Dudley, R. A. (2018). Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 16(7), 829–837. -
Large Scale Semi-Automated Labeling of Routine Free-Text Clinical Records for Deep Learning.
Trivedi, H. M., Panahiazar, M., Liang, A., Lituiev, D., Chang, P., Sohn, J. H., … Hadley, D. (2019). Large Scale Semi-Automated Labeling of Routine Free-Text Clinical Records for Deep Learning. Journal of Digital Imaging, 32(1), 30–37. -
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain.
Ding, Y., Sohn, J. H., Kawczynski, M. G., Trivedi, H., Harnish, R., Jenkins, N. W., … Franc, B. L. (2019). A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain. Radiology, 290(2), 456–464. -
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.
Jones, E. F., Ray, K. M., Li, W., Chien, A. J., Mukhtar, R. A., Esserman, L. J., … Hylton, N. M. (2019). Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol. NPJ Breast Cancer, 5, 12. -
PET/CT Imaging of Human TNFa Using [89Zr]Certolizumab Pegol in a Transgenic Preclinical Model of Rheumatoid Arthritis.
Beckford-Vera, D. R., Gonzalez-Junca, A., Janneck, J. S., Huynh, T. L., Blecha, J. E., Seo, Y., … Franc, B. L. (2019). PET/CT Imaging of Human TNFa Using [89Zr]Certolizumab Pegol in a Transgenic Preclinical Model of Rheumatoid Arthritis. Molecular Imaging and Biology. -
Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment.
Franc, B. L., Thombley, R., Luo, Y., John Boscardin, W., Rugo, H. S., Seidenwurm, D., & Adams Dudley, R. (2020). Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment. The Breast Journal. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy.
Nakamoto, R., Zaba, L. C., Rosenberg, J., Reddy, S. A., Nobashi, T. W., Davidzon, G., … Franc, B. L. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging. -
Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
Duan, H., Ninatti, G., Girod, B., Ferri, V., Kunz, P. L., Fisher, G. A., … Mari, C. (2020). Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET). JOURNAL OF CLINICAL ONCOLOGY, 38(4). -
Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography.
Lee, J. J., Yang, H., Franc, B. L., Iagaru, A., & Davidzon, G. A. (2020). Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. -
Preclinical SPECT and SPECT-CT in Oncology.
Franc, B. L., Seo, Y., Flavell, R., & Aparici, C. M. (2020). Preclinical SPECT and SPECT-CT in Oncology. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer, 216, 359–404. -
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT.
Guja, K. E., Brown, R., Girod, B., Song, H., Harrison, C., Franc, B. L., … Aparici, C. M. (2020). An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. -
Obituary for Sanjiv Sam Gambhir, MD, PhD.
Davidzon, G., Franc, B., Mari Aparici, C., Moradi, F., Nguyen, J., & Iagaru, A. (2020). Obituary for Sanjiv Sam Gambhir, MD, PhD. Clinical Nuclear Medicine. -
Positron Emission Tomography Imaging of Functional TGFbeta Activity and Benefit of TGFbeta Inhibition in Irradiated Intracranial Tumors.
Gonzalez-Junca, A., Reiners, O., Borrero-Garcia, L. D., Beckford-Vera, D., Lazar, A. A., Chou, W., … Barcellos-Hoff, M. H. (2020). Positron Emission Tomography Imaging of Functional TGFbeta Activity and Benefit of TGFbeta Inhibition in Irradiated Intracranial Tumors. International Journal of Radiation Oncology, Biology, Physics. -
Prospective evaluation of F-18-DCFPyL PET/CT in biochemically recurrent prostate cancer: Analysis of lesion localization and distribution.
Song, H., Duan, H., Harrison, C., Guja, K., Hatami, N., Franc, B. L., … Iagaru, A. (2020). Prospective evaluation of F-18-DCFPyL PET/CT in biochemically recurrent prostate cancer: Analysis of lesion localization and distribution. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Extrahepatic Ga-68-DOTATATE-Avid Tumor Volume and serum Chromogranin A Predict Short-Term Outcome of Lu-177-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Song, H., Kunz, P., Franc, B., Moradi, F., Fisher, G., Aparici, C. M., … Davidzon, G. (2020). Extrahepatic Ga-68-DOTATATE-Avid Tumor Volume and serum Chromogranin A Predict Short-Term Outcome of Lu-177-DOTATATE in Late-Stage Metastatic Gastroenteropancreatic Neuroendocrine Tumors. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
Duan, H., Girod, B., Ninatti, G., Ferri, V., Kunz, P., Fisher, G., … Aparici, C. M. (2020). Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs). JOURNAL OF NUCLEAR MEDICINE, 61. -
Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
PSMA-and GRPR-targeted PET: Preliminary Results in Patients with Biochemically Recurrent Prostate Cancer
Baratto, L., Duan, H., Hatami, N., Song, H., Davidzon, G., Franc, B., … Iagaru, A. (2020). PSMA-and GRPR-targeted PET: Preliminary Results in Patients with Biochemically Recurrent Prostate Cancer. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Letter to the Editor: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center".
Franc, B. L., & Iagaru, A. (2020). Letter to the Editor: "Disparities in PET imaging for prostate cancer at a tertiary academic medical center". Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.
Hathi, D. K., Li, W., Seo, Y., Flavell, R. R., Kornak, J., Franc, B. L., … Jones, E. F. (2020). Evaluation of primary breast cancers using dedicated breast PET and whole-body PET. Scientific Reports, 10(1), 21930. -
The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval.
Nakamoto, R., Harrison, C., Song, H., Guja, K. E., Hatami, N., Nguyen, J., … Iagaru, A. (2021). The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Molecular Imaging and Biology. -
Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy.
Nakamoto, R., Zaba, L. C., Liang, T., Reddy, S. A., Davidzon, G., Aparici, C. M., … Franc, B. L. (2021). Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
PROSPECTIVE EVALUATION OF F-18-DCFPYL PET/CT IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: ANALYSIS OF F-18-DCFPYL UPTAKE IN POSSIBLE EXTRA-PELVIC OLIGOMETASTASES
Song, H., Nguyen, J., Moradi, F., Aparici, C. M., Franc, B., Davidzon, G., & Iagaru, A. (2021). PROSPECTIVE EVALUATION OF F-18-DCFPYL PET/CT IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: ANALYSIS OF F-18-DCFPYL UPTAKE IN POSSIBLE EXTRA-PELVIC OLIGOMETASTASES. JOURNAL OF UROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Perfusion Only Scans with and without SPECT/CT in the Era of COVID-19
Zhang, R., Moradi, F., Aparici, C. M., Davidzon, G., Nguyen, J., Iagaru, A., & Franc, B. (2021). Perfusion Only Scans with and without SPECT/CT in the Era of COVID-19. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Phantom study of SPECT/CT augmented reality for intraoperative localization of sentinel lymph nodes in head and neck melanoma.
Nakamoto, R., Zhuo, J., Guja, K. E., Duan, H., Perkins, S. L., Leuze, C., … Franc, B. L. (1800). Phantom study of SPECT/CT augmented reality for intraoperative localization of sentinel lymph nodes in head and neck melanoma. Oral Oncology, 125, 105702. -
Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center
Iagaru, A., & Franc, B. (2021). Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center. JOURNAL OF NUCLEAR MEDICINE, 62(5), 747–748. -
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
Beckford-Vera, D. R., Flavell, R. R., Seo, Y., Martinez-Ortiz, E., Aslam, M., Thanh, C., … Henrich, T. J. (2022). First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nature Communications, 13(1), 1219. -
Prediction of future healthcare expenses of patients from chest radiographs using deep learning: a pilot study.
Sohn, J. H., Chen, Y., Lituiev, D., Yang, J., Ordovas, K., Hadley, D., … Seo, Y. (2022). Prediction of future healthcare expenses of patients from chest radiographs using deep learning: a pilot study. Scientific Reports, 12(1), 8344. -
Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Institution Experience
Duan, H., Ferri, V., Fisher, G. A., Shaheen, S., Davidzon, G. A., Moradi, F., … Aparici, C. M. (2022). Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Institution Experience. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS. -
Hong Song, Heying Duan, Caitlyn Harrison, Kip Guja, Negin Hatami, Judy Nguyen, Benjamin Franc, Farshad Moradi, Carina Mari Aparici, Guido Davidzon, Sandy Srinivas and Andrei lagaru
Song, H., Duan, H., Harrison, C., Guja, K., Hatami, N., Nguyen, J., … Iagaru, A. (2022). Hong Song, Heying Duan, Caitlyn Harrison, Kip Guja, Negin Hatami, Judy Nguyen, Benjamin Franc, Farshad Moradi, Carina Mari Aparici, Guido Davidzon, Sandy Srinivas and Andrei lagaru. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy.
Khessib, T., Franc, B., Yang, E., & Moradi, F. (2023). Retroperitoneal Inflammation Detected on FDG PET/CT in Patient on Long-Term Immunotherapy. Clinical Nuclear Medicine. -
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting.
Song, H., Ferri, V., Duan, H., Aparici, C. M., Davidzon, G., Franc, B. L., … Iagaru, A. (2023). SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting. European Journal of Nuclear Medicine and Molecular Imaging. -
Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program.
Levitte, S., Yarani, R., Ganguly, A., Martin, L., Gubatan, J., Nadel, H. R., … Thakor, A. S. (2023). Case Series of Precision Delivery of Methylprednisolone in Pediatric Inflammatory Bowel Disease: Feasibility, Clinical Outcomes, and Identification of a Vasculitic Transcriptional Program. Journal of Clinical Medicine, 12(6). -
Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression free survival in patients with prostate cancer
Song, H., Sjostrand, K., Duan, H., Ferri, V., Aparici, C. M., Davidzon, G., … Iagaru, A. (2023). Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression free survival in patients with prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Total and Anatomically Contextualized Quantitative 18F-DCFPyL PET at biochemical recurrence predicts subsequent biochemical progression free survival in prostate cancer patients
Song, H., Duan, H., Ferri, V., Na, S. J., Davidzon, G., Franc, B., … Iagaru, A. (2023). Total and Anatomically Contextualized Quantitative 18F-DCFPyL PET at biochemical recurrence predicts subsequent biochemical progression free survival in prostate cancer patients. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
A Case-Based Primer on FDG PET/CT for Imaging Cardiovascular Infections: Protocol, Interpretation, and Pitfalls.
Zhou, W., Moradi, F., Davidzon, G., Song, H., Grady, E., Nguyen, J., … Shah, J. (2023). A Case-Based Primer on FDG PET/CT for Imaging Cardiovascular Infections: Protocol, Interpretation, and Pitfalls. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Rapid dynamic reconstruction using list mode data for monitoring PET image quality accurately predicts final image noise and perceived quality
Moradi, F., Khalighi, M. M., Su, K.-H., Zhang, X., Wollenweber, S., Spangler-Bickell, M., … Iagaru, A. (2023). Rapid dynamic reconstruction using list mode data for monitoring PET image quality accurately predicts final image noise and perceived quality. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.
Song, H., Leonio, M. I., Ferri, V., Duan, H., Aparici, C. M., Davidzon, G., … Iagaru, A. (2024). Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. -
Frequent Amplification and Overexpression of PSMA in Basallike Breast Cancer from Analysis of The Cancer Genome Atlas.
Zhou, W., Halder, S., Herwald, S., Ghijsen, M., Shafi, G., Uttarwar, M., … Kishore, S. (2024). Frequent Amplification and Overexpression of PSMA in Basallike Breast Cancer from Analysis of The Cancer Genome Atlas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
Estrogen Receptor-targeted PET Imaging for Breast Cancer.
Zhou, W., Franc, B. L., DeMartini, W. B., & Rosen, E. L. (2024). Estrogen Receptor-targeted PET Imaging for Breast Cancer. Radiology, 312(2), e240315. -
Total and anatomically contextualized quantitative <SUP>18</SUP>F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression-free survival in patients with prostate cancer.
Song, H., Anand, A., Sjostrand, K., Ferri, V., Duan, H., Shah, J., … Iagaru, A. (2024). Total and anatomically contextualized quantitative 18F-DCFPyL PET at biochemical recurrence to predict subsequent biochemical progression-free survival in patients with prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Assessing the clinical utility of rapid post-therapy whole-body digital SPECT/CT in evaluating early treatment response of <SUP>177</SUP>Lu-PSMA-617 treatment.
Leonio, M. I., Ferri, V., Duan, H., Shah, J., Moradi, F., Mari Aparici, C., … Iagaru, A. (2024). Assessing the clinical utility of rapid post-therapy whole-body digital SPECT/CT in evaluating early treatment response of 177Lu-PSMA-617 treatment. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
-
Pericardial lymph node involvement in lymphoma as identified on PET
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Nuclear Medicine and Molecular Imaging Stanford, CA
Stanford, CA
Nuclear Medicine and Molecular Imaging
300 Pasteur Drive, 2nd Floor C21
Stanford , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records